News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,489 Results
Type
Article (1090)
Company Profile (7)
Press Release (18392)
Section
Business (6272)
Career Advice (30)
Deals (1007)
Drug Development (1507)
Employer Resources (2)
FDA (359)
Job Trends (536)
News (9324)
Policy (732)
Tag
Academia (95)
Adcomms (1)
Allergies (1)
Alliances (1517)
Alzheimer's disease (16)
Antibody-drug conjugate (ADC) (1)
Approvals (356)
Artificial intelligence (3)
Autoimmune disease (1)
Bankruptcy (11)
Best Places to Work (439)
Biotechnology (5)
Brain cancer (2)
Breast cancer (4)
Cancer (29)
Cardiovascular disease (2)
Career advice (28)
Cell therapy (5)
Cervical cancer (1)
Clinical research (1240)
Collaboration (21)
COVID-19 (87)
C-suite (6)
Cystic fibrosis (1)
Data (37)
Depression (1)
Diabetes (5)
Diagnostics (303)
Diversity (1)
Drug discovery (3)
Drug pricing (5)
Duchenne muscular dystrophy (1)
Earnings (1576)
Editorial (1)
Employer branding (1)
Employer resources (1)
Events (2719)
Executive appointments (33)
FDA (376)
Funding (22)
Gene editing (2)
Generative AI (1)
Gene therapy (3)
GLP-1 (14)
Government (127)
Healthcare (594)
IgA nephropathy (2)
Immunology and inflammation (2)
Infectious disease (88)
Inflammatory bowel disease (2)
Influenza (1)
Intellectual property (1)
Interviews (2)
IPO (373)
IRA (2)
Job creations (120)
Job search strategy (23)
Layoffs (11)
Legal (190)
Lung cancer (6)
Lymphoma (2)
Manufacturing (5)
MASH (2)
Medical device (387)
Medtech (387)
Mergers & acquisitions (639)
Metabolic disorders (7)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (20)
NextGen: Class of 2025 (247)
Non-profit (256)
Now hiring (1)
Obesity (2)
Opinion (9)
Ovarian cancer (2)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Patents (1)
Patient recruitment (2)
People (2616)
Pharmaceutical (2)
Pharmacy benefit managers (2)
Phase I (325)
Phase II (529)
Phase III (513)
Pipeline (25)
Policy (6)
Postmarket research (66)
Preclinical (153)
Psychedelics (2)
Radiopharmaceuticals (4)
Rare diseases (5)
Real estate (268)
Regulatory (443)
Reports (2)
Research institute (96)
Resumes & cover letters (5)
RNA editing (1)
Schizophrenia (2)
Series A (5)
Series B (5)
Special edition (2)
Spinal muscular atrophy (11)
Startups (179)
Stomach cancer (1)
Vaccines (15)
Weight loss (2)
Women's health (1)
Date
Today (4)
Last 7 days (15)
Last 30 days (47)
Last 365 days (640)
2025 (201)
2024 (720)
2023 (846)
2022 (1244)
2021 (1475)
2020 (1461)
2019 (1601)
2018 (1227)
2017 (969)
2016 (975)
2015 (1133)
2014 (803)
2013 (799)
2012 (831)
2011 (928)
2010 (706)
Location
Africa (30)
Alabama (1)
Arizona (4)
Asia (1015)
Australia (124)
California (95)
Canada (51)
China (2)
Colorado (6)
Connecticut (6)
Delaware (1)
Europe (2209)
Florida (15)
Georgia (1)
Idaho (1)
Illinois (8)
Indiana (6)
Japan (1)
Kansas (1)
Maine (1)
Maryland (20)
Massachusetts (128)
Michigan (19)
Minnesota (6)
Missouri (1)
Montana (1)
Nevada (1)
New Jersey (17)
New Mexico (2)
New York (19)
North Carolina (84)
Northern California (30)
Ohio (8)
Oregon (2)
Pennsylvania (7)
Rhode Island (3)
South America (28)
Southern California (35)
Tennessee (4)
Texas (14)
United States (500)
Utah (6)
Virginia (2)
Washington D.C. (3)
Washington State (16)
Wisconsin (3)
19,489 Results for "benson hill biosystems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Benson Hill Reports Solid Full-Year 2023 Financial Results, Strengthens Balance Sheet
Benson Hill, Inc. (NYSE:BHIL, the “Company” or “Benson Hill”), an ag-tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the year ended December 31, 2023.
March 14, 2024
·
25 min read
Business
Benson Hill Announces Date of Fourth Quarter and Full Year Earnings Release
Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), an ag tech company unlocking the natural genetic diversity of plants, announced today that it will release its financial results for the full year and fourth quarter ending Dec. 31, 2023, before the market opens on Thursday, March 14, 2024.
February 7, 2024
·
1 min read
BioMidwest
Benson Hill Announces Gains in Soybean Breeding Program; Introduces Five 2024 Soybean Varieties Delivering Higher Protein and Improved Yield Potential
Benson Hill, Inc., an ag tech company unlocking the natural genetic diversity of plants, announced that recent advances in its soybean breeding program will drive the doubling of its seed portfolio by 2025.
January 4, 2024
·
9 min read
Press Releases
Nuclera Appoints Seth Benson as Chief Financial Officer
February 24, 2025
·
2 min read
Press Releases
Oak Hill Bio Enters into Exclusive License Agreement with Roche to Obtain Global Rights for a Phase 3-Ready, Potential Best-in-Class Treatment for Individuals with Angelman Syndrome
April 15, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
January 31, 2025
·
2 min read
Business
Benson Hill Revises Second Quarter 2022 Earnings Release Call Time
Benson Hill, Inc., a food tech company unlocking the natural genetic diversity of plants, announced a revised time for its second quarter earnings call and webcast to 8 a.m. Eastern Time from 8:30 a.m. Eastern Time on Monday, Aug. 8, 2022.
June 30, 2022
·
1 min read
Business
Torus Biosystems Announces Appointment of Nancy Hill to Board of Directors
Torus Biosystems today announced the appointment of Nancy Hill as lead Independent Director to the Company’s Board of Directors.
October 12, 2022
·
3 min read
Biosenta Announces Engagement of Oak Hill Financial Inc.
Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”) announces that it has entered into an agreement with Oak Hill Financial Inc. (“Oak Hill”) to provide business
January 11, 2024
·
3 min read
Press Releases
Rapid Micro Biosystems to Participate in Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
1 of 1,949
Next
